Australia vs United States of America: Treatment success rate: XDR-TB cases
Australia
100
in 2022
United States of America
100
in 2021
Australia rank
1st
United States of America rank
1st
Treatment success rate: XDR-TB cases over time
- Australia
- United States of America
How they compare
Australia currently reports 100 against 100 in United States of America, a difference of 0.
The two have swapped places 4 times across 6 shared years of data; in 2010 it was United States of America ahead.
Australia ranks 1st and United States of America ranks 1st of 82 countries.
Australia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.75 | 47 | 19.75 | Australia |
| 2020s | 66.5 | 50 | 16.5 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Australia or United States of America?
- Australia, at 100 against 100 in United States of America as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between Australia and United States of America?
- 0, with Australia ahead.
- How many years of comparable data are there for Australia and United States of America?
- 6 years are reported by both, from 2010 to 2021.
- How do Australia and United States of America rank globally for treatment success rate: xdr-tb cases?
- Australia ranks 1st and United States of America ranks 1st of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.